StemGenn Therapeutics

StemGenn is dedicated to advancing the field of regenerative medicine & Molecular Medicine by offering the highest quality technology, cellular therapy and training. StemGenn is committed to maintaining its leading position within the infertility sector of the cell technology industry by delivering stem cell therapies and biologics that help address Poor ovarian reserve, Asherman syndrome, Thin Endometrium, Erectile dysfunction, SUI , menopause management and other issues. StemGenn goals are to improve a patient’s quality of life by regenerating their damaged tissue, when possible, and by reducing health care costs and hospitalisations. StemGenn leading procedure , Lipokraft, O-Cell PRP is a clinical adipose cell therapy & concentrated plasma designed to populate regions of scar tissue within a patient’s with new living cells for the purpose of improving function in degenerative conditions. We are an international med tech company that is focused in the field of stem cell & regenerative medicine. We are devoted to developing therapeutic products & services that have the potential to be safer and are more effective than the current standard of care. Our products and services are aimed at providing better treatment and management for the diseases leading to a better quality of life. StemGenn Therapeutics is a Biotechnology Company promoting disruptive regenerative medicines.